CGTX

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Cognition Therapeutics Inc

NASDAQ | CGTX

1.74

USD

$0.00

(

0.00%

)

At Close (As of Oct 14, 2025)

$158.80M

Market Cap

-

P/E Ratio

-0.66

EPS

$3.83

52 Week High

$0.22

52 Week Low

HEALTHCARE

Sector

CGTX Chart

Recent Chart
Price Action

CGTX Technicals

Tags:

CGTX Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$266K
Total Revenue $0
Cost Of Revenue $266K
Costof Goods And Services Sold $266K
Operating Income -$54M
Selling General And Administrative $12M
Research And Development $42M
Operating Expenses $54M
Investment Income Net -
Net Interest Income -$25K
Interest Income -
Interest Expense $25K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $316K
Income Before Tax -$34M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$34M
Comprehensive Income Net Of Tax -
Ebit -$34M
Ebitda -$34M
Net Income -$34M

Revenue & Profitability

Earnings Performance

CGTX Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $30M
Total Current Assets $30M
Cash And Cash Equivalents At Carrying Value $25M
Cash And Short Term Investments $25M
Inventory -
Current Net Receivables $2.7M
Total Non Current Assets $679K
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $1.9M
Other Non Current Assets -
Total Liabilities $11M
Total Current Liabilities $11M
Current Accounts Payable $2M
Deferred Revenue -
Current Debt -
Short Term Debt $472K
Total Non Current Liabilities $342K
Capital Lease Obligations $535K
Long Term Debt -
Current Long Term Debt $279K
Long Term Debt Noncurrent -
Short Long Term Debt Total $814K
Other Current Liabilities $7.6M
Other Non Current Liabilities -
Total Shareholder Equity $19M
Treasury Stock -
Retained Earnings -$175M
Common Stock $60K
Common Stock Shares Outstanding $40M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$28M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $266K
Capital Expenditures $4K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$4K
Cashflow From Financing $24M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$34M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$266K
Total Revenue $0
Cost Of Revenue $266K
Costof Goods And Services Sold $266K
Operating Income -$54M
Selling General And Administrative $12M
Research And Development $42M
Operating Expenses $54M
Investment Income Net -
Net Interest Income -$25K
Interest Income -
Interest Expense $25K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $316K
Income Before Tax -$34M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$34M
Comprehensive Income Net Of Tax -
Ebit -$34M
Ebitda -$34M
Net Income -$34M

CGTX News

CGTX Profile

Cognition Therapeutics Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Cognition Therapeutics, Inc. is a clinical-stage biopharmaceutical firm focused on advancing innovative small molecule therapies aimed at addressing age-related neurodegenerative diseases and retinal disorders. Based in Purchase, New York, the company is at the forefront of research and development, with a strong emphasis on improving cognitive health and vision in the elderly population. By leveraging its proprietary drug design and development capabilities, Cognition Therapeutics seeks to provide transformative treatment options for patients suffering from these increasingly prevalent conditions.

VHAI
0.00%
$0.00
YYAI
-11.76%
$0.15
BURU
-19.92%
$0.41
UGRO
+54.52%
$0.57
BITF
+9.27%
$5.89
NVDA
-4.40%
$180.03
PLUG
+3.84%
$4.05
CGBS
-39.47%
$0.03
NVTS
+26.07%
$12.57
TMQ
+61.58%
$10.60
RGTI
+2.20%
$56.12
CAN
+18.42%
$1.80
DNN
+3.57%
$3.19
LAES
+24.79%
$7.65
INTC
-4.27%
$35.63
BYND
-24.56%
$0.78
JOBY
+7.99%
$18.11
RR
+4.34%
$6.73
RXRX
+6.50%
$5.89
SSKN
+41.55%
$2.18
ITP
+31.01%
$0.34
F
+0.95%
$11.65
EDHL
+114.42%
$1.07
COOT
+46.21%
$0.96
CRML
+28.73%
$29.97
DVLT
+28.82%
$2.19
NAK
+3.75%
$2.76
SOUN
+8.98%
$20.86
ACHR
+1.95%
$13.02
WULF
+10.42%
$15.46
BBD
+1.94%
$3.15
TLRY
-5.32%
$1.60
SOFI
+2.68%
$27.87
GPUS
-5.58%
$0.40
IONZ
+11.73%
$2.57
BTBT
+3.25%
$4.13
QBTS
+6.00%
$43.06
TSLA
-1.52%
$429.24
MARA
+9.88%
$22.24
AMD
+0.77%
$218.09
MNTS
+19.58%
$1.71
AXDX
-61.36%
$0.03
CLF
+0.94%
$13.96
AAL
+3.83%
$12.19
ERIC
+20.56%
$9.85
RIG
-2.50%
$3.12
ETHD
+6.60%
$3.55
UUUU
+10.34%
$26.23
CIFR
+2.70%
$20.89
NIO
-5.29%
$6.80
NUAI
+30.63%
$3.07
NEHC
+30.63%
$3.07
QUBT
+1.49%
$21.78
UAMY
+4.54%
$17.47
IREN
+8.45%
$69.56
ASST
-7.69%
$0.99
CLSK
+9.68%
$21.98
NOK
+4.19%
$5.47
GNPX
+30.15%
$0.25
BTG
+0.56%
$5.34
PLTR
+1.42%
$179.74
APLD
+2.33%
$35.04
AREC
+36.74%
$6.81
ADAP
-11.16%
$0.16
AMZN
-1.67%
$216.39
RF
+2.44%
$25.16
WWR
+35.93%
$3.48
USAR
-2.93%
$37.54
JDZG
+59.57%
$3.00
ABAT
+22.88%
$11.33
T
+2.11%
$26.13
BAC
+2.51%
$50.09
PFE
-0.84%
$24.52
QS
-0.64%
$16.88
BMNR
-6.91%
$52.92
SNAP
-1.61%
$7.92
MP
+3.77%
$98.65
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
BCRX
-8.80%
$6.42
JBLU
+7.91%
$4.91
WFC
+7.14%
$84.56
ONDS
-3.70%
$10.41
AAPL
+0.04%
$247.77
SRM
+53.27%
$10.30
ATXS
+37.07%
$11.61
HPE
+0.80%
$25.00
IONQ
-5.53%
$77.55
AQMS
+198.89%
$29.62
EOSE
-0.41%
$16.98
NAKA
-7.78%
$0.78
KDLY
-7.78%
$0.78
VALE
-0.36%
$10.97
C
+3.89%
$99.84
RGTZ
-5.37%
$8.80
GRAB
-0.33%
$5.91
HOOD
-4.07%
$134.94
BULL
-0.08%
$11.73
WMT
+4.98%
$107.21
GWH
-16.24%
$7.58
VHAI
0.00%
$0.00
YYAI
-11.76%
$0.15
BURU
-19.92%
$0.41
UGRO
+54.52%
$0.57
BITF
+9.27%
$5.89
NVDA
-4.40%
$180.03
PLUG
+3.84%
$4.05
CGBS
-39.47%
$0.03
NVTS
+26.07%
$12.57
TMQ
+61.58%
$10.60
RGTI
+2.20%
$56.12
CAN
+18.42%
$1.80
DNN
+3.57%
$3.19
LAES
+24.79%
$7.65
INTC
-4.27%
$35.63
BYND
-24.56%
$0.78
JOBY
+7.99%
$18.11
RR
+4.34%
$6.73
RXRX
+6.50%
$5.89
SSKN
+41.55%
$2.18
ITP
+31.01%
$0.34
F
+0.95%
$11.65
EDHL
+114.42%
$1.07
COOT
+46.21%
$0.96
CRML
+28.73%
$29.97
DVLT
+28.82%
$2.19
NAK
+3.75%
$2.76
SOUN
+8.98%
$20.86
ACHR
+1.95%
$13.02
WULF
+10.42%
$15.46
BBD
+1.94%
$3.15
TLRY
-5.32%
$1.60
SOFI
+2.68%
$27.87
GPUS
-5.58%
$0.40
IONZ
+11.73%
$2.57
BTBT
+3.25%
$4.13
QBTS
+6.00%
$43.06
TSLA
-1.52%
$429.24
MARA
+9.88%
$22.24
AMD
+0.77%
$218.09
MNTS
+19.58%
$1.71
AXDX
-61.36%
$0.03
CLF
+0.94%
$13.96
AAL
+3.83%
$12.19
ERIC
+20.56%
$9.85
RIG
-2.50%
$3.12
ETHD
+6.60%
$3.55
UUUU
+10.34%
$26.23
CIFR
+2.70%
$20.89
NIO
-5.29%
$6.80
NUAI
+30.63%
$3.07
NEHC
+30.63%
$3.07
QUBT
+1.49%
$21.78
UAMY
+4.54%
$17.47
IREN
+8.45%
$69.56
ASST
-7.69%
$0.99
CLSK
+9.68%
$21.98
NOK
+4.19%
$5.47
GNPX
+30.15%
$0.25
BTG
+0.56%
$5.34
PLTR
+1.42%
$179.74
APLD
+2.33%
$35.04
AREC
+36.74%
$6.81
ADAP
-11.16%
$0.16
AMZN
-1.67%
$216.39
RF
+2.44%
$25.16
WWR
+35.93%
$3.48
USAR
-2.93%
$37.54
JDZG
+59.57%
$3.00
ABAT
+22.88%
$11.33
T
+2.11%
$26.13
BAC
+2.51%
$50.09
PFE
-0.84%
$24.52
QS
-0.64%
$16.88
BMNR
-6.91%
$52.92
SNAP
-1.61%
$7.92
MP
+3.77%
$98.65
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
BCRX
-8.80%
$6.42
JBLU
+7.91%
$4.91
WFC
+7.14%
$84.56
ONDS
-3.70%
$10.41
AAPL
+0.04%
$247.77
SRM
+53.27%
$10.30
ATXS
+37.07%
$11.61
HPE
+0.80%
$25.00
IONQ
-5.53%
$77.55
AQMS
+198.89%
$29.62
EOSE
-0.41%
$16.98
NAKA
-7.78%
$0.78
KDLY
-7.78%
$0.78
VALE
-0.36%
$10.97
C
+3.89%
$99.84
RGTZ
-5.37%
$8.80
GRAB
-0.33%
$5.91
HOOD
-4.07%
$134.94
BULL
-0.08%
$11.73
WMT
+4.98%
$107.21
GWH
-16.24%
$7.58
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.